Sandip Patankar
Family Medicine · Plano, TXNPI 1932395746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 640 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 29.3% of the total. Reporting peaked in 2019 at $2,180 and has fallen 80.5% since, to $424 in 2025. Among family medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 640 payments — averaging $13.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$3K
- Neos Therapeutics, LP$2K
- Corium, LLC$1K
- Tris Pharma Inc$1K
- Supernus Pharmaceuticals, Inc.$754
- Jazz Pharmaceuticals Inc.$210
- plus $1K from 11 others
What the payments were for
- Consulting fees$5506%
- Food & beverage$8,14894%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 187 | $2,547 |
| Neos Therapeutics, LP | 126 | $1,873 |
| Corium, LLC | 98 | $1,199 |
| Tris Pharma Inc | 76 | $1,037 |
| Supernus Pharmaceuticals, Inc. | 53 | $754 |
| Jazz Pharmaceuticals Inc. | 6 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $200 |
| Vertical Pharmaceuticals, LLC | 13 | $185 |
| Collegium Pharmaceutical, Inc. | 14 | $155 |
| Arbor Pharmaceuticals, Inc. | 35 | $138 |
| Adlon Therapeutics L.p. | 7 | $126 |
| Noven Therapeutics, LLC | 6 | $107 |
| Noven Pharmaceuticals, Inc. | 1 | $96 |
| Abbott | 1 | $21 |
| Avion Pharmaceuticals | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Adzenys XR-ODT$675
- Cotempla XR-ODT$675
- Dyanavel XR$228
- JORNAY PM$156
- SUNOSI$127
- Jornay PM 20mg capsules (Bottle of 100)$116
- Quillichew ER$115
- Quillivant XR$115
How this compares
$8,698 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine Sulfate ErDextroamphetamine Sulfate | 12 | $960 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $555 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Plano
- Mahdi AwwadPlano$34K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.